Since its establishment in 2007, Aiweituo has always adhered to providing high-quality injection grade excipients to serve complex formulations, actively promoting the registration and application of pharmaceutical excipients, and has cooperated with numerous clients to complete the related review of multiple varieties.

As of January 1, 2015, CDE showed a total of 6392 registration data for pharmaceutical excipients, involving 1411 companies. among which,Aiweituo (including agents and self-produced varieties) has a total of 38 registration numbers for medicinal excipients, ranking 26th.

Among these over 6300 pieces of data on medicinal excipients, the vast majority are oral or topical grade products. In order to further analyze the registration status of injection grade pharmaceutical excipients, we searched with the keyword "for injection use" and found a total of 260 excipient registration data involving 87 companies. Among them, Avito (including suppliers) has 32 registration numbers for pharmaceutical excipients with the name "for injection", ranking second. After removing duplicate registration data of the same variety of CDE, the injection excipients owned by AvitoCDE registration quantity ranking first.

As of the end of 2024, Avito has completed CDE original and auxiliary package registration for 50 products, of which 17 products have been activated and converted to A. In addition, Avito has also completed DMF registration for 14 products in the United States, effectively helping customers to carry out dual reporting of formulation projects in China and the United States.

From 2007 to 2024, after 17 years of accumulation, Avito has accumulated rich experience in the registration of pharmaceutical excipients and established a excipient product library that spans multiple lines.

From 2025 to 2027, and in the next 17 years, Avito will continue to deepen its cultivation in the field of pharmaceutical excipients, adhere to serving the complex formulation industry with high-quality excipients, and assist domestic pharmaceutical companies in the research and development, production, market launch, and overseas expansion of their projects.

Ai Weituo, persist in walking with you!